Export Controls for BCI Conference at the U.S Department of Commerce

Public Information for Bureau of Industry and Security 2023 Brain-Computer Interface Technology Conference BIS is hosting a two-day hybrid (in-person and virtual) conference with industry experts to further BIS and the public's understanding of the current status and future developments in Brain-Computer Interface (BCI) technology and anticipated future developments in research and applications.

The Conference will take place on February 16 and 17. In-person attendance is limited, but the public is encouraged to attend virtually at this link.

Agenda with complete list of speakers and presenters

Day One

• Theme: State of the Art and Applications
• Welcome and Opening Remarks
• Patient Advocacy and the Need for BCI
• Government Investment & U.S. Leadership in BCI
• State of the Art & Applications
• BCI Commercialization
• Food and Drug Administration (FDA)
• Global Collaboration
• Day One Recording Part 1: link Part 2: link and Presentation Materials link

Day Two

• Theme: Export Controls 101, Neurotech Ethics, and Dual Use
• Welcome and Opening Remarks
• Introduction to Export Control and Intangible Technology
• Neurotech Ethics & Dual Use
• Risk Mitigation Strategies

Day Two Recording Part 1: link Part 2: link Part 3: link and Presentation Materials link

Additional Background:

Link to Federal Register Announcement of event with additional supplementary information here: https://www.govinfo.gov/content/pkg/FR-2023-02-06/pdf/2023-02413.pdf

Link to BIS October 26, 2021, advance notice of proposed rulemaking (ANPRM) materials here: https://www.regulations.gov/docket/BIS-2021-0032  

Register here